Bernstein H, Langer R
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge 02139.
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8751-5. doi: 10.1073/pnas.85.22.8751.
Immobilized-enzyme reactors are beginning to be studied for a variety of therapeutic applications. To facilitate the design of these devices for different clinical situations and a diverse patient population, mathematical models may be valuable. An immobilized-heparinase (EC 4.2.2.7) reactor was selected as a model system. The device removes heparin from blood that has been anticoagulated to prevent thrombus formation. Heparinase was immobilized to cross-linked agarose particles. A mathematical model was developed to describe the clearance of heparin by the reactor ex vivo and compared to experimental clearances measured in sheep. The model accounted for enzymatic degradation as well as the binding of heparin and its breakdown products to antithrombin. The device was modeled as a steady-state continuously stirred tank reactor. Molar conservation equations within the agarose particles accounted for simultaneous diffusion and chemical reaction. The model had no adjustable parameters and was able to predict the clearance of heparin within 5-25% for three different animals and 12 different perfusions.
固定化酶反应器正开始用于各种治疗应用的研究。为便于针对不同临床情况和多样化患者群体设计这些装置,数学模型可能很有价值。选择了一种固定化肝素酶(EC 4.2.2.7)反应器作为模型系统。该装置从已抗凝以防止血栓形成的血液中去除肝素。肝素酶被固定在交联琼脂糖颗粒上。开发了一个数学模型来描述该反应器在体外对肝素的清除情况,并与在绵羊身上测得的实验清除率进行比较。该模型考虑了酶促降解以及肝素及其降解产物与抗凝血酶的结合。该装置被建模为稳态连续搅拌釜式反应器。琼脂糖颗粒内的摩尔守恒方程考虑了同时发生的扩散和化学反应。该模型没有可调参数,能够在三种不同动物和12种不同灌注情况下将肝素清除率的预测误差控制在5%至25%以内。